RxDoctor Payments Data

Payam Moazzaz, MD

Orthopaedic Surgery of the Spine · Oceanside, CANPI 1538304704

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $395,281 of the $487,494 with a category attached, or 81.1%. 23 manufacturers reported payments, led by Kyocera Medical Technologies, Inc. at 46.0% of the total.

$487,494in general payments, 2019–2025

Across 258 payments — averaging $1889.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Kyocera Medical Technologies, Inc.$224K
  • Stryker$123K
  • Alphatec Spine, Inc$49K
  • Renovis Surgical Technologies, Inc.$48K
  • VB Spine LLC$27K
  • Novapproach Spine, LLC$8K
  • plus $8K from 17 others

What the payments were for

  • Royalty or licence$395,28181%
  • Consulting fees$78,42716%
  • Speaking & faculty fees$4,5501%
  • Travel & lodging$5,2381%
  • Food & beverage$3,9981%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$487,494 in reported general payments places this provider in the 85th percentile of 288 orthopaedic surgery of the spine providers in California.

See all orthopaedic surgery of the spine providers in California

Medicare billing

Part B allowed, 2024
$309,477
Medicare patients
326
Services billed
1,357

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen44$518
Cephalexin52$399
Gabapentin34$267
Cyclobenzaprine Hcl47$241
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen14$227
Methylprednisolone13$78

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Oceanside

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →